With a compound annual growth rate (CAGR) of 5.19%, the global VNA and PACS market is expected to grow from its 2022 valuation of USD 3.6 billion to USD 5.4 billion by 2030.
The global VNA & PACS market was valued at USD 2,583.6 million in 2018. Rampant growth in IT healthcare sector and excellent clinician productivity & patient care coordination are the key drivers pertaining to VNA & PACS market growth.
According to World Health Organization (WHO), by 2020 the deaths associated with chronic disease will be 73% and the healthcare burden will be 60% accordingly. Healthcare regulatory agencies worldwide are emphasizing in implementing guidelines pertaining to proper diagnosis of chronic disease and adhering to treatment guidelines & preventive measures to subsequently reduce the mortality rate and healthcare burden associated with chronic disease. Healthcare professionals are relying on electronic healthcare records and patient’s clinical data to assess the health status of ailing patients and address their health issues accordingly. VNA and PACS are employed in catering EHR and clinical data anywhere anytime.
The global VNA & PACS market is segmented by type and modality. The type segment is further categorized as picture archiving and communication system (PACS) and vendor neutral archive (VNA). The modality segment is further classified as digital radiology, computed tomography, magnetic resonance imaging, ultrasound and other imaging modality.
North America is the clear leader in the regional segment for VNA & PACS market representing a market share of 38.51% in 2018. Asia Pacific will be projecting exemplary growth during the forecast period on account of competitive environment faced by key players due to emergence of local IT healthcare firms providing VNA and PACS solutions and developing healthcare infrastructure.
The IT healthcare firms providing VNA & PACS solutions & services are Agfa Healthcare N.V., Cerner Corporation, Carestream, Inc., Fujifilm Corporation, Novarad Corporation, GE Healthcare, Hyland Software, Inc., Koninklijke Philips N.V., Mach7Technologies, Ltd., McKesson Corporation, Siemens Healthineers and Xerox Corporation.
VNA & PACS Market Scope
Metrics | Details |
Base Year | 2023 |
Historic Data | 2018-2022 |
Forecast Period | 2024-2030 |
Study Period | 2018-2030 |
Forecast Unit | Value (USD) |
Revenue forecast in 2030 | USD 5.4 billion |
Growth Rate | CAGR of 5.19 % during 2020-2030 |
Segment Covered | By Type, By Modality, Regions |
Regions Covered | North America, Europe, Asia Pacific, South America, Middle East and Africa |
Key Players Profiled | Agfa Healthcare N.V., Cerner Corporation, Carestream, Inc., Fujifilm Corporation, Novarad Corporation, GE Healthcare, Hyland Software, Inc., Koninklijke Philips N.V., Mach7Technologies, Ltd., McKesson Corporation, Siemens Healthineers and Xerox Corporation. |
Key Segments of the VNA & PACS Market
By Type, (USD Million)
- Vendor Neutral Archive (VNA)
- Picture Archiving & Communication System (PACS)
By Modality, (USD Million)
- Digital Radiology
- Computed Tomography
- Magnetic Resonance Imaging
- Ultrasound
- Others
Regional Overview, (USD Million)
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- Rest of Europe
- Asia Pacific
- China
- Japan
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- GCC
- Rest of MEA
Reasons for the study
- The purpose of the study is to give an exhaustive outlook of the global VNA & PACS market
- The overall segmentation of the VNA & PACS market, especially key segments such as type and modality is thoroughly studied. Vendor neutral archive and other imaging modalities segments are anticipated to be the fastest growing sub segment till 2025
- Developing healthcare infrastructure and rampant growth in local IT healthcare sector in the Asia Pacific regional segment will further drive the VNA & PACS market growth
- Rising public health awareness and constant rise in disease diagnosis will further propel the VNA & PACS market growth
What does the report include?
- The study on the global VNA & PACS market includes qualitative analysis of factors such as drivers, restraints and opportunities
- The report covers qualitative and quantitative analysis of the overall market segmented on the basis of type & modality and breakdown of the same at regional level
- Actual market sizes and forecasts have been provided for all the considered segments
- The study includes the profiles of key market players with a significant global and/or regional presence along with top company positioning
Who should buy this report?
This study is suitable for industry participants and stakeholders in the IT healthcare sector focusing on clinical data storage and information sharing, seeking an in-depth insight into the movement of the VNA & PACS market. The report will benefit:
- Executives of multispecialty hospitals that are engaged in the restoration and storage of electronic health records and clinical data
- Managers within financial institutions looking to publish recent and forecasted statistics pertaining to VNA & PACS solutions
- Venture capitalists, investors, financial institutions, analysts, government organizations, regulatory authorities, policymakers, researchers, strategy managers, and academic institutions looking for insights into the market to determine future strategies
- IT healthcare firms who are looking for new avenues of revenue generation
Frequently Asked Questions (FAQ) :
Archiving is collection of documents, images, medical records and other patient health related information. Picture archiving and communication system (PACS) primary objective is to securely store and digitally transmit electronic images of clinical importance. It eliminated the tedious process of manually feeding and retrieval of sensitive information. Initially radiologist were utilizing PACS to disseminate vital clinical data however in the last decade it has gained popularity among other imaging modalities such as nuclear medicine imaging, ultrasound, magnetic resonance imaging etc. It comprises of components such as hardware imaging machines, a secure network, workstation for processing, viewing and interpretation of images. The issue associated with PACS is the data migration from one healthcare setting to another which is costly and time consuming.
Vendor neutral archive is an application engine which handles data at faster pace. It is placed between the imaging modalities and PACS. It simply decouples workstations and PACS at archival level thereby permitting multiple users to gain access to vital clinical information in real time anytime anywhere. It has been beneficial in increasing workflow efficiency and productivity at a relatively lower cost. Siemens Healthineers vendor neutral archive solution ensures data storage security, management and smooth dissemination. The GE Healthcare has Centricity™ clinical archive solution which provides wide range of interoperability such as HL7, IHE-XDS and IMPI. It ensures neutrality with advanced image lifecycle management capabilities and tag morphing.
It is noteworthy to understand that vendor neutral archive was developed because PACS are highly proprietary and offer limited data management tools, and lacked performance & technology transfer as expected by market experts. Vendor neutral archive are necessary to manage rampant growth anticipated in storage fabrics on account of increasing demand for medical images and unstructured DICOM storage. It will be handy in curtailing the exponential growth of proprietary archives by centralizing the storage of clinical data to a single, scalable repository which is vendor-neutral.
The type segment consists of vendor neutral archive and picture archiving communication systems. It is imperative to understand that modern healthcare providers are facing problems in managing complex clinical data, continuous government interventions in seeking transparency related to sharing of vital information pertaining to patient’s health brings additional burden on healthcare providers. VNA and PACS are very crucial in maintaining mandatory government regulations and streamlining the dissemination of clinical data for multiple users across the globe.
The modality segment comprises of digital radiology, computed tomography, magnetic resonance imaging, ultrasound and other imaging modalities. Digital radiology represents 30.52% market share in 2018 and will exhibit sluggish growth during the forecast period. Other imaging modalities will highlight faster growth owing to technological advancement in nuclear imaging and PET scanning techniques.
The global VNA & PACS market is spread across North America, Europe, Asia Pacific, South America and Middle East & Africa regions. North America presently dominates the regional segment for VNA & PACS market. Existence of developed healthcare infrastructure and increasing public health awareness resulting in early disease diagnosis together drive the VNA & PACS market growth in the region. Europe represents 35.17% market share primarily due to rising prevalence of chronic disease and proactive government initiatives in providing funds to establish VNA & PACS infrastructure to improve patient care coordination. Asia Pacific is keen to register impressive market growth during the forecast period owing to emergence of local IT healthcare firms providing VNA & PACS solutions and developing healthcare infrastructure.